Sklamberg Quoted in Corporate Counsel on Legal Roles in FDA Approval Process
August 18, 2021
Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in a recent article from Corporate Counsel discussing the parts in-house counsel and law firms play in the FDA approval process for drugs and vaccines. Sklamberg, a former FDA deputy commissioner for global regulatory operations, comments on the strategic role of legal counsel, particularly in prioritizing talking points to present before the agency.
» Read the full article (subscription required).